Literature DB >> 27476823

Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma.

T Vescovo1, G Refolo1, G Vitagliano2, G M Fimia3, M Piacentini2.   

Abstract

Hepatitis C virus (HCV) is a major leading cause of hepatocellular carcinoma (HCC). HCV-induced hepatocarcinogenesis is a multistep process resulting from a combination of pathway alterations that are either caused directly by viral factors or immune mediated as a consequence of a chronic state of inflammation. Host genetic variation is now emerging as an additional element that contribute to increase the risk of developing HCC. The advent of direct-acting antiviral agents foresees a rapid decline of HCC rate in HCV patients. However, a full understanding of the HCV-mediated tumourigenic process is required to elucidate if pro-oncogenic signatures may persist after virus clearance, and to identify novel tools for HCC prevention and therapy. In this review, we summarize the current knowledge of the molecular mechanisms responsible for HCV-induced hepatocarcinogenesis.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Genetic variants; Hepatitis C virus; Hepatocellular carcinoma; Hepatocyte apoptosis; Hepatocyte autophagy; Hepatocyte proliferation; Immunomediated liver alterations; Steatohepatitis

Mesh:

Substances:

Year:  2016        PMID: 27476823     DOI: 10.1016/j.cmi.2016.07.019

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  44 in total

1.  NF90 stabilizes cyclin E1 mRNA through phosphorylation of NF90-Ser382 by CDK2.

Authors:  Donglin Ding; Huixing Huang; Quanfu Li; Wenbo Yu; Chenji Wang; Haijie Ma; Jiaxue Wu; Yongjun Dang; Long Yu; Wei Jiang
Journal:  Cell Death Discov       Date:  2020-01-22

Review 2.  The functional role of exosome in hepatocellular carcinoma.

Authors:  Hongyu Liu; Baoguo Li
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-30       Impact factor: 4.553

Review 3.  Hepatocellular Carcinoma: Etiology and Current and Future Drugs.

Authors:  Aastha Jindal; Anusha Thadi; Kunwar Shailubhai
Journal:  J Clin Exp Hepatol       Date:  2019-01-25

4.  A novel microRNA boosts hyper-β-oxidation of fatty acids in liver by impeding CEP350-mediated sequestration of PPARα and thus restricts chronic hepatitis C.

Authors:  Suchandrima Ghosh; Joyeeta Chakraborty; Avijit Goswami; Sayantani Bhowmik; Susree Roy; Amit Ghosh; Sakshi Dokania; Priyanka Kumari; Simanti Datta; Abhijit Chowdhury; Suvendra Nath Bhattacharyya; Raghunath Chatterjee; Soma Banerjee
Journal:  RNA Biol       Date:  2020-06-07       Impact factor: 4.652

5.  Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b.

Authors:  Mohammad Alkhatib; Velia Chiara Di Maio; Valentina De Murtas; Ennio Polilli; Martina Milana; Elisabetta Teti; Gianluca Fiorentino; Vincenza Calvaruso; Silvia Barbaliscia; Ada Bertoli; Rossana Scutari; Luca Carioti; Valeria Cento; Maria Mercedes Santoro; Alessandro Orro; Ivana Maida; Ilaria Lenci; Loredana Sarmati; Antonio Craxì; Caterina Pasquazzi; Giustino Parruti; Sergio Babudieri; Luciano Milanesi; Massimo Andreoni; Mario Angelico; Carlo Federico Perno; Francesca Ceccherini-Silberstein; Valentina Svicher; Romina Salpini
Journal:  Viruses       Date:  2021-04-23       Impact factor: 5.048

6.  Cortactin Interacts with Hepatitis C Virus Core and NS5A Proteins: Implications for Virion Assembly.

Authors:  Lap P Nguyen; Tram T T Nguyen; Huu C Nguyen; Hang T Pham; Kang Min Han; Dong Hwa Choi; Eun-Mee Park; Sang Min Kang; Dongseob Tark; Yun-Sook Lim; Soon B Hwang
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

7.  Using the Electronic Health Record to Characterize the Hepatitis C Virus Care Cascade.

Authors:  Shannon M Christy; Richard R Reich; Julie A Rathwell; Susan T Vadaparampil; Kimberly A Isaacs-Soriano; Mark S Friedman; Richard G Roetzheim; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-04-08       Impact factor: 3.117

Review 8.  Recent Advances in Anticancer Activity of Novel Plant Extracts and Compounds from Curcuma longa in Hepatocellular Carcinoma.

Authors:  Nighat Gull; Fareeha Arshad; Gowhar A Naikoo; Israr Ul Hassan; Mona Zamani Pedram; Arif Ahmad; Alaa A A Aljabali; Vijay Mishra; Saurabh Satija; Nitin Charbe; Poonam Negi; Rohit Goyal; Ángel Serrano-Aroca; Mazhar S Al Zoubi; Mohamed El-Tanani; Murtaza M Tambuwala
Journal:  J Gastrointest Cancer       Date:  2022-03-14

Review 9.  Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection.

Authors:  Mohammad Irshad; Priyanka Gupta; Khushboo Irshad
Journal:  World J Hepatol       Date:  2017-12-28

10.  Prognostic Value of a Novel Signature With Nine Hepatitis C Virus-Induced Genes in Hepatic Cancer by Mining GEO and TCGA Databases.

Authors:  Jianming Wei; Bo Wang; Xibo Gao; Daqing Sun
Journal:  Front Cell Dev Biol       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.